Form 4: Cyanotech Director Michael Davis Increases Stake in Company
SEC Form 4 Filing
Director Michael Davis increased his indirect holdings in Cyanotech through purchases made via a revocable trust.
Summary
- Michael Davis, a director and 10% owner of Cyanotech Corporation, reported changes in his beneficial ownership of the company's common stock.
- On July 26, 2024, and July 29, 2024, Davis acquired 5,000 shares each day at a price of $0.64 per share.
- These purchases were made indirectly through his self-managed Michael Arlen Davis Revocable Trust.
- Following these transactions, Davis's indirect holdings through the trust increased to 1,136,736 shares.
- Davis also has indirect ownership through his spouse (31,250 shares), as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust (150,000 shares), as trustee for Nettizanne Johnstone Davis GST Exempt Trust (58,000 shares), and as trustee for Nyracai Johnstone Davis GST Exempt Trust (58,789 shares).
- The purchases were made pursuant to a Rule 10b5-1(c) trading plan adopted on March 6, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the amount is relatively small and executed under a pre-arranged trading plan, reducing the significance.
Positives
- A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into a company's prospects, although they don't guarantee future performance.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 03-06-2024 | Adoption date of the 10b5-1(c) trading plan |
| 07/26/2024 | Date of first reported transaction: purchase of 5,000 shares at $0.64 |
| 07/29/2024 | Date of second reported transaction: purchase of 5,000 shares at $0.64 |
| 07/30/2024 | Date of Form 4 filing |
Keywords
Cyanotech, insider trading, Form 4, beneficial ownership, Michael Davis, stock purchase, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.